IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSenseĀ® Cryoablation

Go back to IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSenseĀ® Cryoablation
(NASDAQ: ICCM) Delayed: 1.99 -0.07 (3.4%)
Previous Close $2.06    52 Week High
Open $2.11    52 Week Low
Day High $2.16    P/E N/A 
Day Low $1.96    EPS
Volume 159,134